Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 25

1.

Multi-parametric MRI imaging of the prostate-implications for focal therapy.

Wysock JS, Lepor H.

Transl Androl Urol. 2017 Jun;6(3):453-463. doi: 10.21037/tau.2017.04.29. Review.

2.

Management of testicular cancer: NYU case of the month, March 2017.

Wysock JS.

Rev Urol. 2017;19(1):56-59. No abstract available.

3.

Primary penile cancer organ sparing treatment.

Sosnowski R, Kuligowski M, Kuczkiewicz O, Moskal K, Wolski JK, Bjurlin MA, Wysock JS, Pęczkowski P, Protzel C, Demkow T.

Cent European J Urol. 2016;69(4):377-383. doi: 10.5173/ceju.2016.890. Epub 2016 Oct 17. Review.

4.
5.

AUTHOR'S REPLY.

Bjurlin MA, Mendhiratta N, Wysock JS, Taneja SS.

Cent European J Urol. 2016;69(1):24. doi: 10.5173/ceju.2016.r106. Epub 2016 Mar 18. No abstract available.

6.

Multiparametric MRI and targeted prostate biopsy: Improvements in cancer detection, localization, and risk assessment.

Bjurlin MA, Mendhiratta N, Wysock JS, Taneja SS.

Cent European J Urol. 2016;69(1):9-18. doi: 10.5173/ceju.2016.734. Epub 2016 Jan 25. Review.

7.

Predictive value of negative 3T multiparametric magnetic resonance imaging of the prostate on 12-core biopsy results.

Wysock JS, Mendhiratta N, Zattoni F, Meng X, Bjurlin M, Huang WC, Lepor H, Rosenkrantz AB, Taneja SS.

BJU Int. 2016 Oct;118(4):515-20. doi: 10.1111/bju.13427. Epub 2016 Feb 25.

PMID:
26800439
8.

A prospective comparative analysis of the accuracy of HistoScanning and multiparametric magnetic resonance imaging in the localization of prostate cancer among men undergoing radical prostatectomy.

Orczyk C, Rosenkrantz AB, Deng FM, Melamed J, Babb J, Wysock J, Kheterpal E, Huang WC, Stifelman M, Lepor H, Taneja SS.

Urol Oncol. 2016 Jan;34(1):3.e1-8. doi: 10.1016/j.urolonc.2015.07.004. Epub 2015 Aug 31.

PMID:
26338414
9.

Prebiopsy MRI and MRI-ultrasound Fusion-targeted Prostate Biopsy in Men With Previous Negative Biopsies: Impact on Repeat Biopsy Strategies.

Mendhiratta N, Meng X, Rosenkrantz AB, Wysock JS, Fenstermaker M, Huang R, Deng FM, Melamed J, Zhou M, Huang WC, Lepor H, Taneja SS.

Urology. 2015 Dec;86(6):1192-8. doi: 10.1016/j.urology.2015.07.038. Epub 2015 Aug 31.

10.

Relationship Between Prebiopsy Multiparametric Magnetic Resonance Imaging (MRI), Biopsy Indication, and MRI-ultrasound Fusion-targeted Prostate Biopsy Outcomes.

Meng X, Rosenkrantz AB, Mendhiratta N, Fenstermaker M, Huang R, Wysock JS, Bjurlin MA, Marshall S, Deng FM, Zhou M, Melamed J, Huang WC, Lepor H, Taneja SS.

Eur Urol. 2016 Mar;69(3):512-7. doi: 10.1016/j.eururo.2015.06.005. Epub 2015 Jun 22.

11.

Magnetic Resonance Imaging-Ultrasound Fusion Targeted Prostate Biopsy in a Consecutive Cohort of Men with No Previous Biopsy: Reduction of Over Detection through Improved Risk Stratification.

Mendhiratta N, Rosenkrantz AB, Meng X, Wysock JS, Fenstermaker M, Huang R, Deng FM, Melamed J, Zhou M, Huang WC, Lepor H, Taneja SS.

J Urol. 2015 Dec;194(6):1601-6. doi: 10.1016/j.juro.2015.06.078. Epub 2015 Jun 19.

PMID:
26100327
12.

Can selective arterial clamping with fluorescence imaging preserve kidney function during robotic partial nephrectomy?

McClintock TR, Bjurlin MA, Wysock JS, Borofsky MS, Marien TP, Okoro C, Stifelman MD.

Urology. 2014 Aug;84(2):327-32. doi: 10.1016/j.urology.2014.02.044. Epub 2014 Jun 6.

13.

Optimization of prostate biopsy: the role of magnetic resonance imaging targeted biopsy in detection, localization and risk assessment.

Bjurlin MA, Meng X, Le Nobin J, Wysock JS, Lepor H, Rosenkrantz AB, Taneja SS.

J Urol. 2014 Sep;192(3):648-58. doi: 10.1016/j.juro.2014.03.117. Epub 2014 Apr 21. Review.

14.

Optimization of prostate biopsy: review of technique and complications.

Bjurlin MA, Wysock JS, Taneja SS.

Urol Clin North Am. 2014 May;41(2):299-313. doi: 10.1016/j.ucl.2014.01.011. Review.

15.

National trends in the utilization of partial nephrectomy before and after the establishment of AUA guidelines for the management of renal masses.

Bjurlin MA, Walter D, Taksler GB, Huang WC, Wysock JS, Sivarajan G, Loeb S, Taneja SS, Makarov DV.

Urology. 2013 Dec;82(6):1283-9. doi: 10.1016/j.urology.2013.07.068.

16.

A prospective, blinded comparison of magnetic resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: the PROFUS trial.

Wysock JS, Rosenkrantz AB, Huang WC, Stifelman MD, Lepor H, Deng FM, Melamed J, Taneja SS.

Eur Urol. 2014 Aug;66(2):343-51. doi: 10.1016/j.eururo.2013.10.048. Epub 2013 Nov 8.

PMID:
24262102
17.

Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group.

Moore CM, Kasivisvanathan V, Eggener S, Emberton M, Fütterer JJ, Gill IS, Grubb Iii RL, Hadaschik B, Klotz L, Margolis DJ, Marks LS, Melamed J, Oto A, Palmer SL, Pinto P, Puech P, Punwani S, Rosenkrantz AB, Schoots IG, Simon R, Taneja SS, Turkbey B, Ukimura O, van der Meulen J, Villers A, Watanabe Y; START Consortium.

Eur Urol. 2013 Oct;64(4):544-52. doi: 10.1016/j.eururo.2013.03.030. Epub 2013 Mar 20.

PMID:
23537686
18.

Multiphoton microscopy in the evaluation of human bladder biopsies.

Jain M, Robinson BD, Scherr DS, Sterling J, Lee MM, Wysock J, Rubin MA, Maxfield FR, Zipfel WR, Webb WW, Mukherjee S.

Arch Pathol Lab Med. 2012 May;136(5):517-26. doi: 10.5858/arpa.2011-0147-OA.

19.

Outcomes and complications after 532 nm laser prostatectomy in anticoagulated patients with benign prostatic hyperplasia.

Chung DE, Wysock JS, Lee RK, Melamed SR, Kaplan SA, Te AE.

J Urol. 2011 Sep;186(3):977-81. doi: 10.1016/j.juro.2011.04.068. Epub 2011 Jul 24.

PMID:
21791350
20.

Single port donor nephrectomy.

Leeser DB, Wysock J, Gimenez SE, Kapur S, Del Pizzo J.

J Vis Exp. 2011 Mar 12;(49). pii: 2368. doi: 10.3791/2368.

Supplemental Content

Loading ...
Support Center